Most Read This Week
- Ten Practice Changes That I Will Make After Attending ASCO 2022
- Omitting Radiotherapy After Breast-Conserving Surgery in Low-Grade Luminal A Breast Cancer
- Trastuzumab Deruxtecan vs Trastuzumab Emtansine in Patients With HER2+ Unresectable and/or Metastatic Breast Cancer
- Tumor Genomic and Gut Microbiota Association With Clinical Outcomes in Newly Diagnosed Glioblastoma Treated With Atezolizumab, Temozolomide, and Radiation
- Overall Survival With First-Line Palbociclib Plus Letrozole vs Placebo Plus Letrozole in Women With ER+/HER2− Advanced Breast Cancer
Recently Updated
- E-Noses Promising for Diagnosing Cancer from Exhaled Breath
- Prevalence of CRC Screening Remains Low in Those Aged 50 to 54
- Overall Survival With First-Line Palbociclib Plus Letrozole vs Placebo Plus Letrozole in Women With ER+/HER2− Advanced Breast Cancer
- Association of Major Adverse Cardiac Events With Immune Checkpoint Inhibitors
- Longitudinal Molecular Profiling of Circulating Tumor Cells in Metastatic Renal Cell Carcinoma